Full Issue

Individual Articles - Sep/Oct 2011 - Volume 15, Number 5

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2011 Pg. 356	PreScription: Third-party Inequities and Discrimination Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 356	PreScription: American Pharmacists Month: A Time for Taking Responsibility Author(s): Menighan Thomas E
Sep/Oct 2011 Pg. 358-366	Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride Author(s): Zur Eyal
Sep/Oct 2011 Pg. 368-371	Natural Tragedies: Planning for Disasters and Emergencies Author(s): Williams LaVonn A
Sep/Oct 2011 Pg. 372-374	Lessons Learned from a Continuous Quality-Improvement Testing Program Author(s): McElhiney Linda F
Sep/Oct 2011 Pg. 376-380	Magic Mouthwashes: A Literature Review and Discussion of Common Compositions Author(s): McElhiney Linda F
Sep/Oct 2011 Pg. 382-384	Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Author(s): Miller David
Sep/Oct 2011 Pg. 386-387	Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient Author(s): McElhiney Linda F
Sep/Oct 2011 Pg. 388-389	7 Marketing Tactics That Don't Work Author(s): Moore Renee
Sep/Oct 2011 Pg. 390-407	Quality-Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 3: Testimonials and Comparisons Author(s): James Kate, Allred Richard, Latta Kenneth S, McElhiney Linda F, Olson Jacob, Hall Richard M, Baker Chad, Armstrong Nicholas, Janik Peter, Whitehead Paul, Purcell Julian
Sep/Oct 2011 Pg. 408-414	Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 2 Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 416	Calculations Author(s): Stockton Shelly J
Sep/Oct 2011 Pg. 418	Carvedilol 0.625-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 419	Granisetron Hydrochloride 0.2-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 420	Lorazepam 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 421	Metoprolol Tartrate 1.25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 422	Nifedipine 1-mg/500-mg Oral Powder Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 423	Nifedipine 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 424	Rebamipide Rectal Enema Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 425	Sotalol 5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 426	Sulfadiazine 100-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 427	Ursodiol 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 428-434	Study of Microbiological Safety of 25 Oncology Drugs After Multiple Uses in Aseptic Conditions Author(s): Roy Julie, Brault Julie, Joran Pierre, Metrop Raphael, Hildgen Patrice
Sep/Oct 2011 Pg. 435-437	Stability of Clopidogrel in Three Extemporaneously Compounded Oral Liquid Preparations Author(s): Yamreudeewong Weeranuj, Dolence Eric Kurt, Teixeira M Glaucia
Sep/Oct 2011 Pg. 438-439	PostScription: Compounders Go Above and Beyond in the Name of Safety Author(s): Gates Ernest P Jr